FDA Inspection
BrightGene BioMedical Technology Co., Ltd.BrightGene BioMedical Technology Co., Ltd. – FDA Inspection, Sep 9, 2026
Record Details
This FDA Inspection record concerns BrightGene BioMedical Technology Co., Ltd., with an inspection on September 9, 2026, issued by the Office of Inspections and Investigations, covering human drugs.
- Inspection Date
- September 9, 2026
- Product Type
- Human Drugs
View Company Profile
ID · 68f3cded-33e6-453d-ad69-3fbdbacd4ca7
Inspection Facts
- Inspection number
- 1342072
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of BrightGene BioMedical Technology Co., Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 10, 2023 | Not classified | Office of Inspections and Investigations |
Other documents for BrightGene BioMedical Technology Co., Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.